A Food and Drug Administration analysis of survival outcomes comparing the Adjuvant Paclitaxel and Trastuzumab trial with an external control from historical clinical trialsLaleh Amiri‐Kordestani, Julia A. Beaver, Shenghui Tang et al.|Annals of Oncology|2020Cited by 24
Regulatory Considerations for Contribution of Effect of Drugs Used in Combination Regimens: Renal Cell Cancer Case StudiesJamie R. Brewer, Julia A. Beaver, Elaine Chang et al.|Clinical Cancer Research|2020Cited by 8